Paper7697604
Letrozole (CGS 20267). A phase I study of a new potent oral aromatase inhibitor of breast cancer.
Lipton A and 8 others. Cancer, 1995. Cited by 95 papers, by iCite.
Cite this record
ConductScience Library. Letrozole (CGS 20267). A phase I study of a new potent oral aromatase inhibitor of breast cancer. Papers, record 7697604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7697604
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Letrozole (CGS 20267). A phase I study of a new potent oral aromatase inhibitor of breast cancer.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Aromatase Inhibitors | Major topic |
| Breast Neoplasms | Major topic |
| Neoplasms, Hormone-Dependent | Major topic |
| Nitriles | Major topic |
| Triazoles | Major topic |
| Adult | |
| Aged | |
| Estrogen Antagonists | |
| Female | |
| Humans | |
| Letrozole | |
| Middle Aged | |
| Neoplasm Metastasis | |
| Remission Induction |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04421547 | Efficacy of Letrozole in Recurrent Ovarian Cancer | Background |
Source ClinicalTrials.gov
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 95 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42622775 | History of the early development of aromatase inhibitors for treatment of breast cancer. | Breast Cancer Res Treat | 2026 | https://conductscience.org/library/papers/42622775 | PubMed |
| 38983726 | A comparison of letrozole regimens for ovulation induction in women with polycystic ovary syndrome. | F S Rep | 2024 | https://conductscience.org/library/papers/38983726 | PubMed |
| 38911541 | Steroidogenic cytochrome P450 enzymes as drug target. | Toxicol Res | 2024 | https://conductscience.org/library/papers/38911541 | PubMed |
| 37922256 | Effects of dietary aromatase inhibitors on masculinization of rosy barb (Pethia conchonius): Evidence from growth, coloration and gonado-physiological changes. | PLoS One | 2023 | https://conductscience.org/library/papers/37922256 | PubMed |
| 37605693 | Pregnancy Rates in Women With Polycystic Ovary Syndrome (PCOS) Using Letrozole Versus Clomiphene Citrate: A Retrospective Record Review. | Cureus | 2023 | https://conductscience.org/library/papers/37605693 | PubMed |
| 35748065 | Influence of the anti-oestrogens tamoxifen and letrozole on thyroid function in women with early and advanced breast cancer: A systematic review. | Cancer Med | 2023 | https://conductscience.org/library/papers/35748065 | PubMed |
| 32756085 | Comparison of clomiphene and letrozole for superovulation in patients with unexplained infertility undergoing intrauterine insemination: A systematic review and meta-analysis. | Medicine (Baltimore) | 2020 | https://conductscience.org/library/papers/32756085 | PubMed |
| 30851382 | Estrogens and breast cancer: Mechanisms involved in obesity-related development, growth and progression. | J Steroid Biochem Mol Biol | 2019 | https://conductscience.org/library/papers/30851382 | PubMed |
| 29254284 | Post-menopausal breast cancer: from estrogen to androgen receptor. | Oncotarget | 2017 | https://conductscience.org/library/papers/29254284 | PubMed |
| 28854590 | Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. | Hum Reprod | 2017 | https://conductscience.org/library/papers/28854590 | PubMed |
| 28776988 | Comprehensive and Automated Linear Interaction Energy Based Binding-Affinity Prediction for Multifarious Cytochrome P450 Aromatase Inhibitors. | J Chem Inf Model | 2017 | https://conductscience.org/library/papers/28776988 | PubMed |
| 27091422 | A MALDI-MS-based quantitative analytical method for endogenous estrone in human breast cancer cells. | Sci Rep | 2016 | https://conductscience.org/library/papers/27091422 | PubMed |
| 26667449 | Double-Blind, Randomized Trial of Alternative Letrozole Dosing Regimens in Postmenopausal Women with Increased Breast Cancer Risk. | Cancer Prev Res (Phila) | 2016 | https://conductscience.org/library/papers/26667449 | PubMed |
| 26576332 | Altered regulation of PDK4 expression promotes antiestrogen resistance in human breast cancer cells. | Springerplus | 2015 | https://conductscience.org/library/papers/26576332 | PubMed |
| 23997058 | Sex-specific lung diseases: effect of oestrogen on cultured cells and in animal models. | Eur Respir Rev | 2013 | https://conductscience.org/library/papers/23997058 | PubMed |
| 23927370 | Molecular simulations of aromatase reveal new insights into the mechanism of ligand binding. | J Chem Inf Model | 2013 | https://conductscience.org/library/papers/23927370 | PubMed |
| 22006184 | Estrogen receptor-beta mediates the protective effects of aromatase induction in the MMTV-Her-2/neu x aromatase double transgenic mice. | Horm Cancer | 2012 | https://conductscience.org/library/papers/22006184 | PubMed |
| 21681442 | Insight into the binding interactions of CYP450 aromatase inhibitors with their target enzyme: a combined molecular docking and molecular dynamics study. | J Mol Model | 2012 | https://conductscience.org/library/papers/21681442 | PubMed |
| 21494765 | Population pharmacokinetic analysis of letrozole in Japanese postmenopausal women. | Eur J Clin Pharmacol | 2011 | https://conductscience.org/library/papers/21494765 | PubMed |
| 21385795 | Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I/II study. | Oncologist | 2011 | https://conductscience.org/library/papers/21385795 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CYP19A1 | 1588 | PubTator's text mining | https://conductscience.org/library/genes/1588 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7697604
GET https://conductscience.org/api/papers/v1/7697604/cited_by?page=2